Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats

S. Miyamoto, G. E. Duncan, C. E. Marx and J. A. Lieberman, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs, Mol. Psychiatry 10 (2005) 79-104; DOI: 10.1038/sj.mp.4001556.10.1038/sj.mp.4001556Search in Google Scholar

S. Natesan, G. E. Reckless, K. B. Barlow, J. N. Nobrega and S. Kapur, Amisulpride the ‘atypical’ atypical antipsychotic-comparison to haloperidol, risperidone and clozapine, Schizophr. Res. 105 (2008) 224-235; DOI: 10.1016/j.schres.2008.07.005.10.1016/j.schres.2008.07.005Search in Google Scholar

V. Bigliani, R. S. Mulligan, P. D. Acton, D. Visvikis, P. J. Ellm, C. Stephenson, R. W. Kerwin and L. S. Pilowsky, In vivo occupancy of striatal and temporal cortical D₂/D₃ dopamine receptors by typical antipsychotic drugs. [123I] epidepride single photon emission tomography (SPET) study, Brit. J. Psychiat. 175 (1999) 231-238; DOI: 10.1192/bjp.175.3.231.10.1192/bjp.175.3.231Search in Google Scholar

S. Leucht, C. Corves, D. Arbter, R. R. Engel, C. Li and J. M. Davis, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet 373 (2009) 31-41; DOI: 10.1016/S0140-6736(08)61764-X.10.1016/S0140-6736(08)61764-XSearch in Google Scholar

M. L. Wadenberg, S. Kapur, A. Soliman, C. Jones and F. Vaccarino, Dopamine D₂ receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats, Psychopharmacology 150 (2000) 422-429; DOI: 10.1007/s002130000466.10.1007/s002130000466Search in Google Scholar

J. T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn and J. D. Salamone, Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function, Psychopharmacology 132 (1997) 74-81; DOI: 10.1007/s002130050322.10.1007/s002130050322Search in Google Scholar

S. Kapur and P. Seeman, Does fast dissociation from the dopamine D₂ receptor explain the action of atypical antipsychotics?: A new hypothesis, Am. J. Psychiat. 158 (2000) 360-369; DOI: 10.1176/appi.ajp.158.3.360.10.1176/appi.ajp.158.3.360Search in Google Scholar

A. Newman, C. Chaput, L. Verriele and M. J. Millan, Clozapine is a partial agonist at cloned human serotonin 5-HT_1A receptors, Neuropharmacology 35 (1996) 119-121; DOI: 10.1016/0028-3908 (95)00170-0.Search in Google Scholar

S. Szymanski, J. Lieberman, S. Pollack, R. Munne, A. Safferman, J. Kane, M. Kronig and T. Cooper, The dopamine-serotonin relationship in clozapine response, Psychopharmacology 112 (1993) S85-S89; DOI: 10.1007/BF02245011.10.1007/BF02245011Search in Google Scholar

M. Campbell, P. I. Young, D. N. Bateman, J. M. Smith and S. H. Thomas, The use of atypical antipsychotics in the management of schizophrenia, Br. J. Clin. Pharmaco. 47 (1999) 13-22; DOI: 10.1046/j.1365-2125.1999.00849.x.10.1046/j.1365-2125.1999.00849.xSearch in Google Scholar

R. Kumar, G. Palit and B. N. Dhawan, Comparative behavioral effects of typical and atypical antipsychotic drugs in rhesus monkey, Eur. J. Pharmacol. 462 (2003) 133-138; DOI: 10.1016/S0014-2999(02)02957-6.10.1016/S0014-2999(02)02957-6Search in Google Scholar

R. A. Bressan, K. Erlandsson, H. M. Jones, R. S. Mulligan, P. J. Ell and L. S. Pilowsky, Optimizing limbic selective D₂/D₃ receptor occupancy by risperidone: a [123I]-epidepride SPET study, J. Clin. Psychopharm. 23 (2003) 5-14; DOI: 10.1097/00004714-200302000-00002.10.1097/00004714-200302000-00002Search in Google Scholar

D. J. Haleem, F. Batool, N. H. Khan, N. Kamil, O. Ali, Z. S. Saify and M. A. Haleem, Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats, Med. Sci. Monit. 8 (2002) 354-361.Search in Google Scholar

F. Batool, S. Ahmed and D. J. Haleem, Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex, J. Coll. Physicians Surg. Pak. 9 (2009) 139-145.Search in Google Scholar

D. J. Haleem, Z. S. Saify, S. Siddiqui, F. Batool and M. A. Haleem, Pre- and postsynaptic responses to 1-(1-naphthylpiperazine) following adaptation to stress in rats, Prog. Neuro-Psychoph. 26 (2002) 149-56; DOI: 10.1016/S0278-5846(01)00240-8.10.1016/S0278-5846(01)00240-8Search in Google Scholar

L. S. Pilowsky, D. C. Costa, P. J. Ell, N. P. Verhoeff, R. M. Murray and R. W. Kerwin, D₂ dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study, Brit. J. Psychiat. 164 (1994) 16-26; DOI: 10.1192/bjp.164.1.16.10.1192/bjp.164.1.16Search in Google Scholar

Q. C. Meng, Y. F. Chen and S. Oparil, A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC, Life Sci. 44 (1989) 1207-1213; DOI: 10.1016/0024-3205(89)90316-0.10.1016/0024-3205(89)90316-0Search in Google Scholar

N. Samad, F. Batool and D. J. Haleem, Neurochemical and behavioral effects of 8-OH-DPAT following exposure to restraint stress in rats, Pharmacol. Rep. 59 (2007) 173-180.Search in Google Scholar

J. de Jong, U. R. Tjaden, E. Visser and W. H. Meijer, Determination of serotonin and 5-hydroxy-indoleacetic acid in urine by reversed-phase ion-pair partition chromatography with fluorimetric detection, J. Chromatogr. 7 (1987) 85-94.10.1016/0378-4347(87)80268-2Search in Google Scholar

L. Farde, A. L. Nordstrom, F. A. Wiesel, S. Pauli, C. Halldin and G. Sedvall, Positron emission tomographic analysis of central D₁ and D₂ dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects, Arch. Gen. Psychiat. 49 (1992) 538-544; DOI: 10.1016/0024-3205(78)90035-8.10.1016/0024-3205(78)90035-8Search in Google Scholar

T. J. Crow, E. C. Johnstone, A. J. Longden and F. Owen, Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process, Life Sci. 23 (1978) 563-567; DOI: 10.1016/0024-3205(78)90035-8.10.1016/0024-3205(78)90035-8Search in Google Scholar

D. Pickar, T. P. Su, D. R. Weinberger, R. Coppola, A. K. Malhotra, M. B. Knable, K. S. Lee, J. Gorey, J. J. Bartko, A. Breier and J. Hsiao, Individual variation in D₂ dopamine receptor occupancy in clozapine-treated patients, Am. J. Psychiat. 153 (1996) 1571-1578.10.1176/ajp.153.12.1571Search in Google Scholar

H. Y. Meltzer and M. Huang, In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems, Prog. Brain Res. 172 (2008) 177-197; DOI: 10.1016/S0079-6123(08)00909-6.10.1016/S0079-6123(08)00909-6Search in Google Scholar

X. Xiberas, J. L. Martinot, L. Mallet, E. Artiges, C. Loc'H, B. Mazière and M. L. Paillère-Martinot, Extrastriatal and striatal D₂ dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia, Brit. J. Psychiat. 179 (2001) 503-508; DOI: 10.1192/bjp.179.6.503.10.1192/bjp.179.6.50311731352Search in Google Scholar

S. Nyberg, L. Farde, L. Eriksson, C. Halldin and B. Eriksson, 5-HT₂ and D₂ dopamine receptor occupancy in the living human brain. A PET study with risperidone, Psychopharmacology 110 (1993) 265-272; DOI: 10.1007/BF02251280.10.1007/BF022512807530376Search in Google Scholar